Damage of kidney glomerular podocytes observed in LN8–10 suggests that increased expression of APOL1 risk variants in podocytes of SLE patients may contribute to faster progression to LN and LN-ESRD. This evidence concerns the gene APOL1 and systemic lupus erythematosus.